2004;20:199-206. Pembrolizumab Investigator’s Brochure, edition 16.0, dated 29 June 2018. Perez-Gracia JL, Labiano S, Rodriguez-Ruiz ME, et al. Orchestrating immune check -point blockade for cancer immunotherapy in combinations. Curr Opin Immunol. 2014;27:89 -97. Pinilla-Ibarz J, Cathcart K, Scheinberg DA. CML vaccines as a paradigm of the specific immunotherapy of cancer. Blood Rev. 2000;14:111-20 Pinilla-Ibarz J, May RJ, Korontsvit T, et al. Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein. Leukemia. 2006;20:2025-33. Provenzano E, Byrne DJ, Russell PA, et al. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple -negative tumours. Histopathology.